Acronym
MoST 17 (substudies 38-39)
Project Title
A single arm, open label, signal-seeking, phase II, trial of tepotinib in patients with advanced non-small cell lung cancer harbouring MET exon 14 skipping mutations detected by comprehensive genomic profiling
Principal Investigator
Keywords
Adv NSCLC harbouring MET exon 14 skipping mutations
Project Type
Interventional/Clinical trials research
